UNVERIFIEDSingle Source
Acquired resistance to the RAS(ON) multi-selective inhibitor daraxonrasib guides rational combination therapy strategies in pancreatic cancer - nature.com
Nature|8/11/2026
R
RAS
24 stories tracked
Executive summary being generated...
Lindy
0
Breaking
0
Unverified
1
Activity (Last 30 Days)
1
2026-08-112026-08-11
Top Publishers
Nature1 stories